Work

Abstract 1849: Developing a formulation of MDM2 inhibitor: Idasanutlin for enhanced stability, solubility, and anticancer activity in p53 sensitive lung cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1849

Authors: Bhoomi Dholariya, Akanksha Patel, Henis Patel, Ketan Patel

Institution: St. John's University

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409629070

Cites:

Cited by:

Related to: 10